Literature DB >> 2570096

Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

J A Snook1, R W Chapman, G K Sachdev, A Heryet, P M Kelly, K A Fleming, D P Jewell.   

Abstract

The relative distribution of lymphocyte subpopulations in the blood and liver of patients with primary sclerosing cholangitis (PSC) and related diseases has been studied using immunoenzyme techniques. The peripheral blood CD4/CD8 T lymphocyte ratio was significantly higher in active ulcerative colitis (UC) and in PSC with inactive UC than in inactive UC alone. In contrast, no relationship with disease activity was seen in Crohn's disease. The portal tract t lymphocyte count per high power field (mean +/- S.D.) was higher in pre-cirrhotic PSC (173 +/- 105) and primary biliary cirrhosis (PBC: 210 +/- 110) than in histologically normal liver (42 +/- 27). However, the overall portal tract CD4/CD8 ratio was similar in PSC (1.49), PBC (1.89) and normal controls (1.63). The results are consistent with immunological involvement in the pathogenesis of PSC, but argue against the hypothesis that changes in the peripheral blood T cell subsets are due to sequestration at the site of tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570096     DOI: 10.1016/0168-8278(89)90073-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Immunopathogenesis of primary sclerosing cholangitis.

Authors:  Joy Worthington; Sue Cullen; Roger Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 3.  Etiopathogenesis of primary sclerosing cholangitis.

Authors:  Roger Chapman; Sue Cullen
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

4.  Tissue distribution of autoantigen specific for primary sclerosing cholangitis.

Authors:  S K Lo; R W Chapman; K A Fleming
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

Review 5.  The immunology of primary sclerosing cholangitis.

Authors:  R W Chapman
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione.

Authors:  Halyna Kuznietsova; Iryna Byelinska; Natalia Dziubenko; Oksana Lynchak; Demyd Milokhov; Olga Khilya; Nataliya Finiuk; Olga Klyuchivska; Rostyslav Stoika; Volodymyr Rybalchenko
Journal:  Mol Cell Biochem       Date:  2021-04-01       Impact factor: 3.396

Review 7.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

8.  Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.

Authors:  G Senaldi; B Portmann; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

9.  Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.

Authors:  S K Lo; K A Fleming; R W Chapman
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.